In two weeks, France’s Council of Ministers is expected to approve a package of reforms that will significantly improve creditor rights in the country’s restructuring and insolvency proceedings
The Irish Takeover Panel ‘s is just as strong The December sale of biotech firm Élan to Perrigo brought to an end one of last year's most watched hostile takeover sagas, and has revealed the Irish Takeover Panel's unwavering approach to its rules. The $8.6 billion acquisition by the US pharmaceutical company came off the back of the Irish target's defence of Royalty Pharma's $6.8 billion hostile offer.
The December sale of biotech firm Élan to Perrigo brought to an end one of last year’s most watched hostile takeover sagas, and has revealed the Irish Takeover Panel’s unwavering approach to its rules
A recent judgment by Germany's Federal Supreme Court that makes it easier for public companies to delist is tipped to facilitate take-privates and spur new public takeover tactics.
Industry support for an EU-wide covered bonds framework has grown over the past 12 months, with investors and issuers agreeing that harmonisation would help safeguard the asset class’s preferential regulatory treatment
Conditional pass-through and soft bullet structures will come to the fore in next year’s European covered bond market, as issuers look at new ways to deal with short-term liquidity gaps
A recent judgment by Germany’s Federal Supreme Court that makes it easier for public companies to delist is tipped to facilitate take-privates and spur new public takeover tactics
